Search Results - "Pinzi, Mario"

Efficacy and Tolerability of Bupropion in Major Depressive Disorder with Comorbid Anxiety Symptoms: A Systematic Review.

Authors: Pinzi, Mario Cuomo, Alessandro Koukouna, Despoina et al.

Source: International Journal of Molecular Sciences. Dec2025, Vol. 26 Issue 24, p11767. 13p.

The Connectomic Glutamate Framework for Depression: Bridging Molecular Plasticity and Network Reorganization.

Authors: Carmellini, Pietro Pinzi, Mario Rescalli, Maria Beatrice et al.

Source: Brain Sciences (2076-3425). Jan2026, Vol. 16 Issue 1, p18. 24p.

Inflammatory and Immune Biomarkers in Mood Disorders: From Mechanistic Pathways to Clinical Translation.

Authors: Pinzi, Mario Fagiolini, Andrea Koukouna, Despoina et al.

Source: Cells (2073-4409). Oct2025, Vol. 14 Issue 19, p1558. 22p.

Insights into the Incidence, Course, and Management of Lithium-Induced Hypothyroidism in Real-World Psychiatric Practice in Italy.

Authors: Pardossi, Simone Pinzi, Mario Cattolico, Matteo et al.

Source: Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1425. 16p.

The Monoamine–Glutamate Continuum of Depression: A Neurobiological Framework for Precision Psychiatry.

Authors: Carmellini, Pietro Cuomo, Alessandro Rescalli, Maria Beatrice et al.

Source: Pharmaceuticals (14248247). May2026, Vol. 19 Issue 5, p662. 22p.

Long-Acting Injectable Antipsychotics in Adolescents: From Current Evidence and Gaps to Clinical Practice.

Authors: Pardossi, Simone Cuomo, Alessandro Gualtieri, Giacomo et al.

Source: Pharmaceuticals (14248247). Oct2025, Vol. 18 Issue 10, p1571. 16p.

Cariprazine in Bipolar Disorder and Substance Use: A Dual Approach to Treatment?

Authors: Pardossi, Simone Cuomo, Alessandro Koukouna, Despoina et al.

Source: Pharmaceuticals (14248247). Nov2024, Vol. 17 Issue 11, p1464. 9p.

Valproate-Enhanced Protocols for Alcohol Withdrawal Syndrome: A Brief Review and Retrospective Study of Efficacy and the Ability to Reduce Benzodiazepine Use.

Authors: Pardossi, Simone Cuomo, Alessandro Gualtieri, Giacomo et al.

Source: Pharmaceuticals (14248247). Jun2025, Vol. 18 Issue 6, p855. 10p.

Methylphenidate in Borderline Personality Disorder: Assessing Its Therapeutic Potential and Limitations.

Authors: Pardossi, Simone Cuomo, Alessandro Koukouna, Despoina et al.

Source: Life (2075-1729). Mar2025, Vol. 15 Issue 3, p380. 15p.